PHX Energy Receives TSX Approval for Renewal of Normal Course Issuer Bid

PHX Energy Receives TSX Approval for Renewal of Normal Course Issuer Bid GlobeNewswire August 13, 2025 CALGARY, Alberta, Aug. 13, 2025 (GLOBE NEWSWIRE) — PHX Energy Services Corp. (“PHX Energy” or the “Corporation“) (TSX: PHX) today announced that the Toronto Stock Exchange (“TSX“) has accepted PHX Energy's notice of intention to renew its normal course […]

Replimune Group, Inc. (REPL) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of September 22, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / August 13, 2025 / If you suffered a loss on your Replimune Group, Inc. (NASDAQ:REPL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/replimune-group-inc-lawsuit-submission-form?prid=161340&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Securities Lawsuit Alert: Novo Nordisk A/S (NVO) Investors – Contact Levi & Korsinsky Before September 30, 2025

NEW YORK, NY / ACCESS Newswire / August 13, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form-3?prid=161339&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Securities Fraud Class Action Filed Against Capricor Therapeutics, Inc. (CAPR) – Levi & Korsinsky Reminds Investors of September 15, 2025

NEW YORK, NY / ACCESS Newswire / August 13, 2025 / If you suffered a loss on your Capricor Therapeutics, Inc. (NASDAQ:CAPR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/capricor-therapeutics-inc-lawsuit-submission-form-2?prid=161338&wire=1&utm_campaign=27 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Flow Capital Announces Q2 2025 Financial Results

(TSX-V:FW), Loan Interest Revenue up 54% and Recurring Free Cash Flow up 212% year over year TORONTO, ON, Aug. 13, 2025 (GLOBE NEWSWIRE) — Flow Capital Corp. (TSXV:FW), a leading provider of flexible growth capital and alternative debt solutions, announces its unaudited financial and operating results for the three- and six-month periods ended June 30,

Flow Capital Announces Q2 2025 Financial Results

Flow Capital Announces Q2 2025 Financial Results GlobeNewswire August 13, 2025 Loan Interest Revenue up 54% and Recurring Free Cash Flow up 212% year over year TORONTO, ON, Aug. 13, 2025 (GLOBE NEWSWIRE) — Flow Capital Corp. (TSXV:FW), a leading provider of flexible growth capital and alternative debt solutions, announces its unaudited financial and operating

Quest Diagnostics Declares Quarterly Cash Dividend

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of$0.80per share, payableonOctober 20, 2025to shareholders of record ofQuest Diagnostics common stock onOctober 3, 2025. https://mma.prnewswire.com/media/200883/quest_diagnostics_incorporated_logo_logo.jpg About Quest DiagnosticsQuest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ANRO

(NYSE:ANRO), NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Alto Neuroscience, Inc. (NYSE: ANRO): (i) pursuant and/or traceable to Alto's initial public offering conducted on or about February 2, 2024 (the “IPO”); and/or (ii) securities between February 2, 2024

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ANRO

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ANRO GlobeNewswire August 13, 2025 NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Alto Neuroscience, Inc. (NYSE: ANRO): (i)

A New Chapter in Leadership: Announcing Four New Partners at Percy Law Group, PC

Since 1994, Percy Law Group has been built on a shared commitment – to the clients who place their trust in us, to the values that guide us, and to each other. That commitment remains at the heart of everything we do, and today we're proud to take an important step forward in the future

Scroll to Top